These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study. Schrag A; Siddiqui UF; Anastasiou Z; Weintraub D; Schott JM Lancet Neurol; 2017 Jan; 16(1):66-75. PubMed ID: 27866858 [TBL] [Abstract][Full Text] [Related]
3. Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers. Arnaldi D; De Carli F; Famà F; Brugnolo A; Girtler N; Picco A; Pardini M; Accardo J; Proietti L; Massa F; Bauckneht M; Morbelli S; Sambuceti G; Nobili F Mov Disord; 2017 Dec; 32(12):1738-1747. PubMed ID: 29119593 [TBL] [Abstract][Full Text] [Related]
4. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease. Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203 [TBL] [Abstract][Full Text] [Related]
6. Do cognition and other non-motor symptoms decline similarly among patients with Parkinson's disease motor subtypes? Findings from a 5-year prospective study. Arie L; Herman T; Shema-Shiratzky S; Giladi N; Hausdorff JM J Neurol; 2017 Oct; 264(10):2149-2157. PubMed ID: 28879438 [TBL] [Abstract][Full Text] [Related]
7. Influence of depression in mild Parkinson's disease on longitudinal motor and cognitive function. Ng A; Chander RJ; Tan LC; Kandiah N Parkinsonism Relat Disord; 2015 Sep; 21(9):1056-60. PubMed ID: 26117438 [TBL] [Abstract][Full Text] [Related]
8. Utility and limitations of Addenbrooke's Cognitive Examination-Revised for detecting mild cognitive impairment in Parkinson's disease. Komadina NC; Terpening Z; Huang Y; Halliday GM; Naismith SL; Lewis SJ Dement Geriatr Cogn Disord; 2011; 31(5):349-57. PubMed ID: 21613789 [TBL] [Abstract][Full Text] [Related]
9. Subcortical shape analysis of progressive mild cognitive impairment in Parkinson's disease. Chung SJ; Shin JH; Cho KH; Lee Y; Sohn YH; Seong JK; Lee PH Mov Disord; 2017 Oct; 32(10):1447-1456. PubMed ID: 28737237 [TBL] [Abstract][Full Text] [Related]
10. Progression of dysprosody in Parkinson's disease over time--a longitudinal study. Skodda S; Rinsche H; Schlegel U Mov Disord; 2009 Apr; 24(5):716-22. PubMed ID: 19117364 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder. Chahine LM; Xie SX; Simuni T; Tran B; Postuma R; Amara A; Oertel WH; Iranzo A; Scordia C; Fullard M; Linder C; Purri R; Darin A; Rennert L; Videnovic A; Del Riva P; Weintraub D Parkinsonism Relat Disord; 2016 Jun; 27():102-6. PubMed ID: 27010070 [TBL] [Abstract][Full Text] [Related]
12. Extended "Timed Up and Go" assessment as a clinical indicator of cognitive state in Parkinson's disease. Evans T; Jefferson A; Byrnes M; Walters S; Ghosh S; Mastaglia FL; Power B; Anderton RS J Neurol Sci; 2017 Apr; 375():86-91. PubMed ID: 28320196 [TBL] [Abstract][Full Text] [Related]
13. Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings. Chahine LM; Weintraub D; Hawkins KA; Siderowf A; Eberly S; Oakes D; Seibyl J; Stern MB; Marek K; Jennings D; Mov Disord; 2016 Jan; 31(1):86-94. PubMed ID: 26293177 [TBL] [Abstract][Full Text] [Related]
14. Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson's disease. Jones JD; Burroughs M; Apodaca M; Bunch J Neuropsychology; 2020 Jan; 34(1):24-30. PubMed ID: 31219297 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease. Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730 [TBL] [Abstract][Full Text] [Related]
16. REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up. Sinforiani E; Pacchetti C; Zangaglia R; Pasotti C; Manni R; Nappi G Mov Disord; 2008 Jul; 23(10):1441-5. PubMed ID: 18512749 [TBL] [Abstract][Full Text] [Related]
17. Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders. Siri C; Cilia R; Reali E; Pozzi B; Cereda E; Colombo A; Meucci N; Canesi M; Zecchinelli AL; Tesei S; Mariani CB; Sacilotto G; Zini M; Pezzoli G Mov Disord; 2015 Apr; 30(5):696-704. PubMed ID: 25757654 [TBL] [Abstract][Full Text] [Related]
18. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease. Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439 [TBL] [Abstract][Full Text] [Related]